Frontlight ResearchEarly access
Trial site
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Melanoma3 trials
- Triple-negative breast cancer3 trials
- Kidney cancer2 trials
- Metastatic breast cancer2 trials
- Childhood cancers1 trial
- Endometrial cancer1 trial
- Hodgkin lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 310 trials
- Phase 43 trials
- Phase 21 trial
- Status
- Recruiting6 trials
- Completed4 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC5 trials
- Replimune, Inc.2 trials
- AstraZeneca1 trial
- Bayer1 trial
- BioNTech SE1 trial
- and 4 more
Running trials
Recruiting
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
The assessment of bevacizumab dose equivalence in ovarian cancer
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma2 recruiting
- Triple-negative breast cancer2 recruiting
- Childhood cancers1 recruiting
- Endometrial cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026